National Metabolic Biochemistry Network Guidelines for the investigation of hypoglycaemia in infants and children

Similar documents
Staff at the Nottingham Children s Hospital. Guidelines process; paediatric endocrinology team

UK NATIONAL METABOLIC BIOCHEMISTRY NETWORK GUIDELINES FOR THE INVESTIGATION OF HYPERAMMONAEMIA

Module : Clinical correlates of disorders of metabolism Block 3, Week 2

بنام خدا هیپوگلیسمی درنوزادان و گاالکتوزمی دکتر انتظاری

Hypoglycemia in congenital hyperinsulinism

NEONATAL HYPOGLYCEMIA HEATHER MCKNIGHT-MENCI, MSN, CRNP CHILDREN S HOSPITAL OF PHILADELPHIA

Hyperglycaemia. Clinical presentation. Definition of hyperglycaemia. Approach to the problem

Paediatric Clinical Chemistry

Neonatal Hypoglycaemia

Hypoglycaemia of the neonate. Dr. L.G. Lloyd Dept. Paediatrics

INBORN ERRORS OF METABOLISM (IEM) IAP UG Teaching slides

e-learning Fatty Acid Oxidation Defects Camilla Reed and Dr Simon Olpin Sheffield Children s Hospital

CARE OF THE NEWBORN HYPOGLYCAEMIA

Guideline for the Prevention and Management of Neonatal Hypoglycaemia GL359

The laboratory investigation of lactic acidaemia. J Bonham/T Laing

Paediatric Hypoglycaemia and the Laboratory. AACB Webinar, 8 th April 2015 Tina Yen

Neonatal Hypoglycemia

10. ACUTE COMPLICATIONS OF DIABETES MELLITUS

Not Your Typical Case of Ketotic Hypoglycemia

3 HYDROXY 3 METHYLGLUTARYL CoA (3 HMG CoA) LYASE DEFICIENCY RECOMMENDATIONS ON EMERGENCY MANAGEMENT OF METABOLIC DISEASES

Inborn Errors of Metabolism in the Emergency Department. Will Davies June 2014

Training Syllabus CLINICAL SYLLABUS

Metabolic diseases of the liver

Clinical Guideline. SPEG MCN Protocols Sub Group SPEG Steering Group

Carnitine palmitoyl transferase 2 deficiency (CPT2) is a rare inherited disorder that occurs when

Neonatal Hypoglycaemia Guidelines

Clinical Director for Women s and Children s Directorate

THE GLUCOSE-FATTY ACID-KETONE BODY CYCLE Role of ketone bodies as respiratory substrates and metabolic signals

Fatty Acid Oxidation Disorders

Overview. o Limitations o Normal regulation of blood glucose o Definition o Symptoms o Clinical forms o Pathophysiology o Treatment.

Organic acidaemias (OAs) & Urea cycle disorders (UCDs) PRESENTATION & MANAGEMENT

ANATOMY OF A METABOLIC CRISIS: FAOD-style. Mark S. Korson, MD Tufts Medical Center Boston, MA

SYLLABUS FOR TRAINING IN CLINICAL PAEDIATRIC METABOLIC MEDICINE

Energy metabolism - the overview

LRI Children s Hospital

Deb Cobie Judy Evans Professionally Approved By Dr Saravanan Consultant Lead for Risk Management June 2009

NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST: Clinical Chemistry Guidelines

Protein & Amino Acid Metabolism

Fatty Acid Oxidation Disorders- an update. Fiona Carragher Biochemical Sciences, GSTS Pathology St Thomas Hospital, London

Beyond the Naked Eye: A Case Presentation on a Rare Form of Congenital Hyperinsulinism (HI) Patient Demographics 5/12/2016

Urea Cycle Defects. Dr Mick Henderson. Biochemical Genetics Leeds Teaching Hospitals Trust. MetBioNet IEM Introductory Training

LESSON 2.4 WORKBOOK. Part two: Glucose homeostasis in the blood Un-Storing energy

ACUTE & CHRONIC ETHANOL EFFECTS An Overview

Guideline for the diagnosis and management of isovaleryl-coa-dehydrogenase deficiency (isovaleric acidemia) - a systematic review -

ISOVALERIC ACIDAEMIA -ACUTE DECOMPENSATION (standard version)

Hypoglycaemic disorders

THE ED APPROACH OF THE CHILD WITH SUSPECTED METABOLIC DISEASE

Syllabus for Training in Inborn Errors of Metabolism for Scientists and Medically Qualified Laboratory Staff

The spectrum and outcome of the. neonates with inborn errors of. metabolism at a tertiary care hospital

Neonatal Biochemistry Investigation for Inherited Metabolic Disorders (IMDs)

Lynne A. Wolfe, MS, ACNP, PNP, BC Department of Genetics Yale School of Medicine

Learning Objectives. At the conclusion of this module, participants should be better able to:

Glycogen Storage Disease

Medium-chain acyl-coa dehydrogenase deficiency

Fatty acid oxidation. Naomi Rankin

Work-Up and Initial Management of Common Metabolic Emergencies in the Inpatient Setting

Guidelines for the Prevention and Management of Hypoglycaemia

UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES Discipline of Biochemistry and Molecular Biology

Prevention and Management of Hypoglycaemia

Chapter 24 Lecture Outline

Newborn Hypoglycemia

INTRAVENOUS FLUIDS PRINCIPLES

INTRAVENOUS FLUID THERAPY

Hormonal Regulations Of Glucose Metabolism & DM

Understanding metabolic disease

INTEGRATION OF METABOLISM

W1A- Cases I Learned From

Introduction to Organic Acidemias. Hilary Vernon, MD PhD Assistant Professor of Genetic Medicine Johns Hopkins University 7.25.

Isovaleric Acidemia: Quick reference guide

7/11/2018. Oral Dextrose Gel Treatment for Newborns with Hypoglycemia Reduces NICU Admissions DISCLOSURE. Objectives

Neonatal Hypoglycemia. Presented By : Kamlah Olaimat 25\7\2010

Robert Barski. Biochemical Genetics St James s University Hospital, Leeds. MetBioNet IEM Introductory Training

Diabetes Mellitus (DM) Chronic metabolic disorder with a predisposition of hyperglycaemia (increased blood glucose).

PHARMACOLOGY AND PHARMACOKINETICS

Newborn Screening & Methods for Diagnosing Inborn Errors of Metabolism

Suspected Metabolic Disease in the Newborn Period Acute Management "What do I do?" Barbara Marriage, PhD RD Abbott Nutrition

METABOLISM CATABOLIC Carbohydrates Lipids Proteins

Information for health professionals

Dialosa 1 mg, 2 mg, 3 mg, 4 mg and 6 mg tablets Glimepiride

The Adrenals Are a key factor in all hormonal issues Because the adrenals can convert one hormone to another they play a role like no other in the bod

DIABETES MELLITUS. IAP UG Teaching slides

Lipid Metabolism. Remember fats?? Triacylglycerols - major form of energy storage in animals

EXAM COVER SHEET. Course Code: CLS 432. Course Description: Clinical Biochemistry. Final Exam. Duration: 2 hour. 1st semester 1432/1433.

Metabolic Disorders. Chapter Thomson - Wadsworth

PRACTICE GUIDELINES WOMEN S HEALTH PROGRAM

CDE Exam Preparation Presented by Wendy Graham RD CDE May 4, 2017

CHAPTER 24: Carbohydrate, Lipid, & Protein Metabolism. General, Organic, & Biological Chemistry Janice Gorzynski Smith

The breakdown of fats to provide energy occurs in segregated membrane-bound compartments

Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015

Neurodevelopmental Risk?

Unstable diabetes. Hypoglycaemia. Type 1 diabetes. Type 2 diabetes

Acylcarnitine measurement in blood spots: methodological aspects, problems and pitfalls with reference to the ERNDIM QA scheme

Hypoglycemia. When recognized early, hypoglycemia can be treated successfully.

UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY

Fatty Acid Oxidation Disorders

Organic Acid Disorders

Objectives. Why is blood glucose important? Hypoglycaemia. Hyperglycaemia. Acute Diabetes Emergencies (DKA,HONK)

DIABETES 20/02/2014 WHAT IS DIABETES? GLUCOSE WHAT IS DIABETES? GLUCOSE HOMEOSTASIS GLUCOSE METABOLISM

Very-long-chain acyl-coa dehydrogenase deficiency

Hypoglycemia, Electrolyte disturbances and acid-base imbalances

Transcription:

National Metabolic Biochemistry Network Guidelines for the investigation of hypoglycaemia in infants and children Aim To provide guidance on the biochemical investigation of hypoglycaemia in infants and children in the non-specialist setting, particularly in relation to the investigation of inherited defects of intermediary metabolism. Introduction Hypoglycaemia is usually defined as a blood glucose of less than 2.6 mmol/l. POCT (point of care testing) devices, are at their least accurate in the low part of their range and it is important to confirm any suspected hypoglycaemia by a accurate laboratory based measurement of glucose. Treatment should not be delayed by waiting for the laboratory glucose but, if possible, appropriate samples should be collected before giving glucose to allow identification of the underlying cause. When to suspect hypoglycaemia? There is usually compelling clinical evidence of symptomatic hypoglycaemia. The early features are associated with the adrenergic response. Neuroglycopaenic symptoms follow and become more predominant as the hypoglycaemia persists. Adrenergic symptoms include pallor, anxiety, sweating, tachypnoea tremor, weakness, nausea and vomiting. Neuroglycopenic symptoms include jitteriness, hunger, abdominal pain, apnoea, headache, confusion, feeding problems, visual disturbances and convulsions and coma. The predominance and severity of symptoms depend on the age of the patient and the rapidity of onset and duration of the hypoglycaemia. The investigation and treatment of symptomatic hypoglycaemia is a clinical emergency as delayed treatment leads to a risk of permanent brain damage. - 1 -

Causes of hypoglycaemia Causes of hypoglycaemia may be split into several main groups: Endocrine Hyperinsulinism Adrenal insufficiency Hypopituitarism Growth Hormone Deficiency Hypothyroidism Metabolic Disorders of Fatty Acid Oxidation and Carnitine Transport Disorders of Carbohydrate Metabolism Disorders of Organic Acid Metabolism Disorders of Gluconeogenesis Other Causes Neonatal complications: prematurity, birth asphyxia, congenital heart defects, infants of diabetic mother secondary hyperinsulinism Drug Related: insulin, alcohol, aspirin, chemotherapy Liver and multi-organ failure Sepsis, Gastroenteritis Idopathic ketotic hypoglycaemia The most common cause for hypoglycaemia in children after the neonatal period is idiopathic ketotic hypoglycaemia. This is usually precipitated by an often relatively mild illness. Taking a good clinical history may help in directing the investigations. Age and presentation are important clinical clues. Any history of drug or alcohol including inhaled steroids needs to be noted. The main points to note include the time since the last meal and whether there is hepatomegaly, liver dysfunction, short stature, hyper pigmentation or small genitalia. High glucose requirements (>10 mg/kg/min) indicate hyperinsulinism (Table one causes of hypoglycaemia). Neonatal hypoglycaemia Biochemical hypoglycaemia is common in the neonatal period (<72 hours after birth) prior to establishing feeds. In these infants the full biochemical screen is not usually required unless the hypoglycaemia does not respond to a feed or if the blood glucose remains persistently or recurrently low. It is important to remember that in neonate hypoglycaemia is commonly secondary to septicaemia, severe systemic illness, intrauterine growth retardation or maternal diabetes. - 2 -

Investigations of hypoglycaemia 1. Before giving glucose draw blood for following analytes: Analyte Glucose 3 OH butyrate Free Fatty Acids Lactate Insulin Cortisol Growth Hormone Amino Acids Acyl carnitines Minimum volume and common preservative 2ml Fluoride Oxalate * 3ml Lithium Heparin * 1ml Lithium Heparin or 2-3 blood spots collected on a Guthrie Card * Save any residual plasma from these samples as this may be used for further tests if indicated *check with local laboratory for sample types and minimum volumes In some hospitals it may be appropriate to assemble all the necessary bottles and prepared specimen request forms for ease of use by medical staff. The hypoglycaemic pack should ensure that all the necessary investigations are undertaken. DO NOT DELAY CORRECTING HYPOGLYCAEMIA IF THE BLOOD IS DIFFICULT TO OBTAIN. 2. First line investigations (samples can be taken after glucose has been given) Blood gases Liver function tests Urea Electrolytes Ammonia Save any residual plasma for further tests 3. Collect first passed urine sample for - Ketones Reducing substances Organic acids Toxicology screen (only required if there is a clinical suspicion of factitious or accidental illness). - 3 -

Interpretation of tests The results of these investigations should be evaluated in the context of the clinical symptoms and a differential diagnosis established. See table two for some examples of interpretation. Further specialist investigations may be indicated these tests are usually undertaken by specialist metabolic or endocrine laboratories. For details of specimen requirements by specialist metabolic laboratories see www.metbio.net metabolic assay directory. Prolonged fast tests On occasion it may be necessary to provoke hypoglycaemia by undertaking a prolonged fasting test. This is potentially a very dangerous procedure and should only be carried out under close medical supervision and after discussion with a metabolic specialist. It is essential that a metabolic screen (urine organic acids and plasma/blood spot acylcarnitines) is carried out prior to any fast and normal results have been obtained. - 4 -

Table two Examples of interpretation of the biochemical results (please note this is not an exhaustive list of interpretation but an aid to basic biochemistry/metabolic tests in investigating hypoglycaemia. General biochemistry Intermediary metabolites: Free fatty acids 3-hydroxybutyrate Glucose Lactate General biochemistry is unlikely to give a definitive cause for the hypoglycaemia but some clues into a metabolic cause can be derived from them, some examples include: Low sodium with raised potassium will be seen in many endocrine disorders associated with low glucocorticoids. Abnormal liver function tests are seen in liver failure and in numerous inherited metabolic defects (e.g. the glycogen storage diseases). A raised lactate may also indicate a glycogen storage disease or defect of energy metabolism. An unexplained acidosis with an increased anion gap may indicate a defect of organic acid metabolism, particularly if the lactate concentration is insufficient to explain the finding. Many organic acidaemias are associated with hyperammonaemia. Sample must be taken at time of hypoglycaemia to allow accurate interpretation. 1. Low FFA and 3-hydroxybutyrate concentrations at time of hypoglycaemia suggest hyperinsulinism 2. FFA/3-hydroxybutyrate ratio 1 indicates appropriate lipolytic and ketogenic response to hypoglycaemia 3. FFA/3-hydroxybutyrate ratio >2 suggests a FA oxidation defect Note that neonates may have a poor metabolic response to hypoglycaemia and patients on chemotherapy/tpn or with liver disease may produce an unusual pattern of intermediary metabolites in response to hypoglycaemia. See appendix one for further interpretation. - 5 -

Endocrine tests Insulin, cortisol and growth hormone Amino acids Acylcarnitines Organic acids Urine chemistry Detectable insulin in a hypoglycaemic sample indicates hyperinsulinism. Low cortisol indicates either hypoadrenalism or hypopituitarism further tests, such as dynamic function tests, are required. Low growth hormone may indicate hypopituitarism or isolated growth hormone deficiency Raised ketogenic (branched chain) and gluconeogenic amino acids are seen in ketotic hypoglycaemia. Low plasma amino acids are noted in anabolic patients or patients with poor protein reserves. Raised ketogenic (branched chain) and gluconeogenic amino acids are seen in ketotic hypoglycaemia. Low plasma amino acids are noted in anabolic patients or patients with poor protein reserves. Specific acylcarnitine species will be raised if there is a fatty acid oxidation defect or organic acidaemia causing the hypoglycaemia. A specific pattern of acylcarnitines will be observed as a response to a ketogenic and lipolytic response to a metabolic stress. Ketone bodies and dicarboxylic acids are seen as part of the normal response to fasting hypoglycaemia. Specific organic acids will usually be present in a crisis sample from patients with fatty acid oxidation disorders or organic acidaemias. High lactate levels are seen in patients with GSD type I and defects of gluconeogenesis as well as the congenital lactic acidaemias and organic acidaemias (when they are accompanied by more specific findings). Glycerol is often present in the urine of patients with fructose bisphosphatase deficiency (as well as glycerol kinase deficiency). Urinary ketones are often absent or inappropriately low in fatty acid oxidation defects Urinary reducing substances will be positive in disorders of sugar metabolism (e.g. Galactosaemia). This is particularly important if the urine is negative for glucose (test by specific glucose dipsticks). - 6 -

Authorship: 2 nd Revised Edition:Jim Bonham FRCPath Tim Lang FRCPath Consultant Clinical Scientist Consultant Clinical Scientist Sheffield Children s (NHS) FT University Hospital of North Durham 1 st Revised Edition: Camilla Reed DipRCPath Tim Lang FRCPath Clinical Scientist Clinical Scientist Sheffield Children s Hospital Belfast HSC Trust 1 st Edition: Helen Losty FRCPath Consultant Clinical Scientist. Date of 2 nd revision: 02/11 Suggested review date: 02/13 Disclaimer These are laboratory guidelines reflecting current best practice in specialist metabolic laboratories in the UK. They are not evidence based but reflect expert opinion. The network cannot accept any responsibility for the use of these guidelines. - 7 -

Appendix one. Algorithm for the interpretation of intermediary metabolites. Blood Glucose <2.6mmol/L Free Fatty Acids/3Hydroxybutyrate (FFA/3OHB) Evidence of lipolysis and ketogenesis Absent lipolytic and ketogenic response FFA/3OHB 1 FFA/3OHB >2 Hyperinsulinism or possibly pan hypopituitarism Normal lactate Raised lactate Check for Fatty Acid Oxidation defect Ketotic hypoglycaemia, Check infection Check endocrine Check secondary metabolic conditions Check for GSD s Check for glycogen storage disorders (GSD s) Gluconeogenic disorders Respiratory Chain disorders - 8 -